Stocks
Telomir Pharmaceuticals, Inc.TELO
NASDAQHealthcareBiotechnology$0.98
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing small-molecule therapeutics targeting age-related diseases, with a focus on metal ion modulation to address conditions like Parkinson's disease and other neurodegenerative disorders. Its lead candidate, TEL-01, is in early-stage trials, and the company's progress is tracked by investors interested in the longevity and neurodegeneration space.
52W Range: $0.89-$1.58
Congressional Interest in Telomir Pharmaceuticals, Inc. (TELO)
No congressional trades have been disclosed for Telomir Pharmaceuticals, Inc. (TELO) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading TELO?
No congressional trades found for this stock.